EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER
Biliary Fibrosis: Pathophysiology and translational opportunitiesMay, 12-13 Florence
N. Poster
Poster title
Applicant name
Status
 |
|
|
|
| P05-01 | Long-term treatment with fibrates and ursodeoxycholic acid in people with primary sclerosing cholangitis is safe and associated with persistent clinical and biochemical improvement | Matteo Peviani |  Received |
 |
|||
| P01-01 | Acute hepatocytic loss of endosomal sorting complex Retromer increases proliferation of biliary epithelial cells (BECs) | Markus Barbosa | Received |
|
|||
| P04-01 | Chronic ketamine-induced sclerosing cholangitis associated with early inflammatory bowel disease after long term topical use | Gerond Lake-Bakaar MD. PhD, | Received |
|
|||
| P03-01 | CRISPR-engineered chemically-derived hepatic progenitor cancer organoid recapitulates intrahepatic cholangiocarcinoma carcinogenesis and pathophysiology | Michael Adisasmita | Received |
|
|||
| P02-1 | Liquid biopsy protein biomarkers of cholangiocarcinoma risk, early diagnosis and survival mirroring tumor cells | Ainhoa Lapitz | Received |
|
|||
| P02-02 | Functional dichotomy of biliary primary cilia in liver injury and cholangiocarcinoma development | Jinbiao Chen | Received |
|
|||
| P03-02 | Metabolic rewiring of cystic cholangiocytes improves mitochondrial dynamics and bioenergetics ameliorating the pathogenesis of polycystic liver disease in experimental models | Enara Markaide | Received |
|
|||
| P04-02 | Mice lacking the NO receptor develop biliary fibrosis and become worsen upon feeding Western diet | Muhammad Ashfaq Khan | Received |
|
|||
| P01-02 | An organotypic model of ductular reaction reveals a role of lipid biosynthesis in biliary cell activation | Giovanni Sorrentino | Received |
|
|||
| P05-2 | scRNA transcriptomics analysis of cellular cross talk in fibrocystin-defective mice revelas a central role for cholangiocytes, neutrophils and double-negative T cells | Zehra Syeda | Received |
|
|||
| P04-03 | Thy-1 expression in liver histology correlates with fibrosis grading in patients with primary biliary cholangitis | Mirjam Kolev | Received |
|
|||
| P05-03 | Claudin-1 is a therapeutic target for primary sclerosing cholangitis | Fabio Del Zompo | Received |
|
|||
| P03-3 | Large CD103 CD69 CD8 T cells consistently invade biliary epithelial cells in patients with primary biliary cholangitis | Scott Davies | Received |
|
|||
| P02-03 | Hematopoietic-biliary organoids as a model for liver development and injury | Susanna Quach | Received |
|
|||
| P01-03 | Quantitative MRCP differentiates between malignant and benign biliary obstructions | Sarah Finnegan | Received |
|
|||
| P03-04 | Targeting OX40 signalling to modulate regulatory T cells and reduce biliary fibrosis | Wei-Yu Lu | Received |
|
|||
| P01-04 | Characterizing and manipulating GPR35-dependent mast cell activity in PSC | Georg Schneditz | Received |
|
|||
| P04-04 | Primary biliary cholangitis symptoms are reduced in Mcpip1fl/flAlbCre mice after pharmacological treatment | Katarzyna Trzos | Received |
|
|||
| P05-04 | Dimethyl-fumarate attenuates cholestatic liver injury in mice | Ester Dohnalkova | Received |
|
|||
| P02-04 | Identification of the role of osteopontin in biliary atresia | Natalia Nieto | Received |
|
|||
| P03-05 | Combined inhibition of bile salt synthesis and intestinal bile salt uptake ameliorates cholestatic liver damage and reduces colonic bile salt levels in mice | Stan van de Graaf | Received |
|
|||
| P01-05 | Necroptosis contributes to liver inflammation and fibrosis in experimental primary sclerosing cholangitis | Pierre-Antoine Soret | Received |
|
|||
| P02-05 | Transcriptomic risk score predicts response to obeticholic acid and identifies genes linked with metabolic remodelling, autophagy, senescence and fibrosis in patients with PBC | Hussain Syed | Received |
|
|||
| P04-05 | Mertk-expressing macrophages promote the malignant features of cholangiocarcinoma cells | Mirella Pastore | Received |
|
|||
| P01-06 | Multimodal decoding of the mesenchymal landscape of human biliary fibrosis | David Wilson | Received |
|
|||
| P05-06 | Recurrence of primary sclerosing cholangitis after liver transplantation: a single center data | Elisa Catanzaro | Received |
|
|||
| P02-06 | CD8 T cells from patient with primary biliary cholangitis express e-cadherin upon T cell receptor activation and invade biliary epithelial cells through e-cadherin-beta-catenin interaction | Vincenzo Ronca | Received |
|
|||
| P04-06 | Biliary atrasia human cholangiocyte organoids demonstrate increased oxidative stress response | Yara Hamody | Received |
|
|||
| P03-06 | Beta-caryophyllene a CB2 specific agonist prevents the development of hepatopulmonary syndrome in experimental model of biliary cirrhosis | Akash Mourya | Received |
|
|||
| P04-07 | Oval cells as new players of the inflammatory response during cholestatic liver damage: role of the EGFR pathway | Aránzazu Sánchez | Received |
|
|||
| P02-07 | Mitochondrial dynamics and autophagy are disturbed in experimental models of primary biliary cholangitis, contributing to disease pathogenesis | Irune Lasa | Received |
|
|||
| P05-07 | Hepatic recompensation upon treatment with ursodeoxycholic acid in PBC patients with decompensated cirrhosis | Lukas Burghart | Received |
|
|||
| P01-07 | Silencing CNNM4 in cholangiocarcinoma inhibits tumoral progression by means of non-canonical ferroptosis | Maria Mercado-Gómez | Received |
|
|||
| P03-07 | Patient proteomic data and mouse model reinforce the proinflammatory role of CCL24 in cholestatic disease | Greenman Raanan | Received |
|
|||
| P02-08 | Identification of a functional relationship between MEK5-ERK5 pathway and hypoxia inducible factor 1-alfa | Alessio Menconi | Received |
|
|||
| P03-08 | Non-invasive evaluation of progression to primary biliary cholangitis in patients with positive antimitochondrial antibodies | MARTA ALONSO PEÑA | Received |
|
|||
| P04-08 | Radiomics features for risk stratification in primary sclerosing cholangitis: a proof-of-concept study | Laura Cristoferi | Received |
|
|||
| P01-08 | Harnessing immune dysregulation in the search for serum biomarkers for diagnosis and prognosis of primary sclerosing cholangitis | Lander Heyerick | Received |
|
|||
| P05-08 | Liver re-transplantation for recurrent primary sclerosing cholangitis: how far we can go? | Chiara Mazzarelli | Received |
|
|||
| P04-09 | Bile duct injury in mdr2 knockout mice can be repaired with n-acetylcysteine treatment | Adi Har-Zahav | Received |
|
|||
| P02-09 | Primary cilia as a targetable node between biliary injury, senescence and regeneration in liver transplantation | Sofia Ferreira Gonzalez | Received |
|
|||
| P01-09 | Beta 7 integrin and L-in contribute to cholestatic liver disease in mice | Agnes Seeger | Received |
|
|||
| P05-09 | Biliary senescence affects the transcriptomic landscape of murine hepatocytes | Marisa F. Ferreira | Received |
|
|||
| P03-09 | Primary sclerosing cholangitis with features of autoimmune hepatitis: phenotypic characterization and prognosis | Mirjam Kolev | Received |
|
|||
| P05-10 | Extracellular matrix remodeling in the progression of primary sclerosing cholangitis to cholangiocarcinoma: insights from an animal model | Massimiliano Cadamuro | Received |
|
|||
| P04-10 | Increased protein tyrosine phosphatase non-receptor type 2 activity in primary sclerosing cholangitis | Madita Determann | Received |
|
|||
| P02-10 | Neutrophils in the pathogenesis of primary sclerosing cholangitis | Nidhi Jalan-Sakrikar | Received |
|
|||
| P01-10 | Dynamics of spleen stiffness measurement in patients with primary biliary cholangitis predict disease progression: a pilot study | Micol Cittone | Received |
|
|||
| P03-10 | A3907, a systemic ASBT inhibitor, improves cholestasis and biliary fibrosis in mice by multi-organ activity and shows translational relevance to human | Francisco J. Caballero | Received |
|
|||
Biliary Fibrosis: Pathophysiology and translational opportunities
May, 12-13 Florence
Search and consult posters online
in an exclusive section
for each poster
in an exclusive section
for each poster
ACTIVE FROM 12/05/2023 TO 12/05/2024
Poster
Gallery
Gallery
Upload
Poster
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
Forum
|
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress.
|
|
||
|
||||
Poster submission deadline 08/05/2023
|
|
